684 related articles for article (PubMed ID: 22570277)
21. Calcineurin governs thermotolerance and virulence of Cryptococcus gattii.
Chen YL; Lehman VN; Lewit Y; Averette AF; Heitman J
G3 (Bethesda); 2013 Mar; 3(3):527-39. PubMed ID: 23450261
[TBL] [Abstract][Full Text] [Related]
22. Differences between Cryptococcus neoformans and Cryptococcus gattii in the Molecular Mechanisms Governing Utilization of D-Amino Acids as the Sole Nitrogen Source.
Chang YC; Khanal Lamichhane A; Bradley J; Rodgers L; Ngamskulrungroj P; Kwon-Chung KJ
PLoS One; 2015; 10(7):e0131865. PubMed ID: 26132227
[TBL] [Abstract][Full Text] [Related]
23. Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species.
Yang DH; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
mBio; 2023 Feb; 14(1):e0345122. PubMed ID: 36656038
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
25. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii.
Torda A; Kumar RK; Jones PD
Pathology; 2001 Nov; 33(4):475-8. PubMed ID: 11827415
[TBL] [Abstract][Full Text] [Related]
26. Cryptococcus gattii: a resurgent fungal pathogen.
Chaturvedi V; Chaturvedi S
Trends Microbiol; 2011 Nov; 19(11):564-71. PubMed ID: 21880492
[TBL] [Abstract][Full Text] [Related]
27. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Kassi FK; Bellet V; Drakulovski P; Krasteva D; Roger F; Valérie BA; Aboubakar T; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Yavo W; Menan HIE; Bertout S
J Med Microbiol; 2018 Jan; 67(1):87-96. PubMed ID: 29214970
[TBL] [Abstract][Full Text] [Related]
28. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
29. Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.
Urai M; Kaneko Y; Ueno K; Okubo Y; Aizawa T; Fukazawa H; Sugita T; Ohno H; Shibuya K; Kinjo Y; Miyazaki Y
Front Cell Infect Microbiol; 2015; 5():101. PubMed ID: 26779451
[TBL] [Abstract][Full Text] [Related]
30. Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265.
Sorrell TC; Juillard PG; Djordjevic JT; Kaufman-Francis K; Dietmann A; Milonig A; Combes V; Grau GE
Microbes Infect; 2016 Jan; 18(1):57-67. PubMed ID: 26369713
[TBL] [Abstract][Full Text] [Related]
31. Dectin-3 Recognizes Glucuronoxylomannan of
Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
Front Immunol; 2018; 9():1781. PubMed ID: 30131805
[No Abstract] [Full Text] [Related]
32. Cryptococcus gattii infections.
Chen SC; Meyer W; Sorrell TC
Clin Microbiol Rev; 2014 Oct; 27(4):980-1024. PubMed ID: 25278580
[TBL] [Abstract][Full Text] [Related]
33. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
34. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
35. A new method for studying cryptococcosis in a murine model using 99mTc-Cryptococcus gattii.
Costa MC; Mata LM; Ribeiro NQ; Santos APN; Oliveira LVN; Vilela RVR; Cardoso VN; Fernandes SOA; Santos DA
Med Mycol; 2018 Jun; 56(4):479-484. PubMed ID: 28992125
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil-mediated antifungal activity against highly virulent Cryptococcus gattii strain R265.
Ueno K; Yanagihara N; Otani Y; Shimizu K; Kinjo Y; Miyazaki Y
Med Mycol; 2019 Nov; 57(8):1046-1054. PubMed ID: 30668754
[TBL] [Abstract][Full Text] [Related]
37. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
[No Abstract] [Full Text] [Related]
38. Cryptococcus gattii infections: contemporary aspects of epidemiology, clinical manifestations and management of infection.
McMullan BJ; Sorrell TC; Chen SC
Future Microbiol; 2013 Dec; 8(12):1613-31. PubMed ID: 24266360
[TBL] [Abstract][Full Text] [Related]
39. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
40. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
Hansakon A; Ngamskulrungroj P; Angkasekwinai P
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
